Writing Group Members et al, Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 333, 447–454 (2016).
Walker, G. B., Jadhav, A. P. & Jovin, T. G. Assessing the efficacy of endovascular therapy in stroke treatments: updates from the new generation of trials. Expert. Rev. Cardiovasc. Ther. 15, 757–766 (2017).
Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomized trials. Lancet 387, 1723–1731 (2016).
Sommer, C. J. Ischemic stroke: experimental models and reality. Acta Neuropathol. 133, 245–261 (2017).
Shi, L. et al. A new era for stroke therapy: integrating neurovascular protection with optimal reperfusion. J. Cereb. Blood Flow. Metab. 38, 2073–2091 (2018).
O’Collins, V. E. et al. 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467–477 (2006).
Fisher, M. et al. Update of the Stroke Therapy Academic Industry Roundtable preclinical recommendations. Stroke 40, 2244–2250 (2009).
Wu, D., Yue, F., Zou, C., Chan, P. & Zhang, Y. A. Analysis of glucose metabolism in cynomolgus monkeys during aging. Biogerontology 13, 147–155 (2012).
Astrup, J., Siesjö, B. K. & Symon, L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 12, 723–725 (1981).
Cook, D. J., Teves, L. & Tymianski, M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483, 213–217 (2012).
Marshall, J. W. et al. NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 32, 190–198 (2001).
Herrmann, A. M. et al. Large animals in neurointerventional research: a systematic review on models, techniques and their application in endovascular procedures for stroke, aneurysms and vascular malformations. J. Cereb. Blood Flow. Metab. 39, 375–394 (2019).
Hill, M. D. et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 395, 878–887 (2020).
Mayor-Nunez, D. et al. Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke. Sci. Transl. Med. 13, eabb1498 (2021).
Roitberg, B. et al. Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurol. Res. 25, 68–78 (2003).
Wu, D. et al. Endovascular ischemic stroke models of adult rhesus monkeys: a comparison of two endovascular methods. Sci. Rep. 6, 31608 (2016).
Wu, D. et al. Selective intraarterial brain cooling improves long-term outcomes in a non-human primate model of embolic stroke: efficacy depending on reperfusion status. J. Cereb. Blood Flow. Metab. 40, 1415–1426 (2020).
Wu, L. et al. Intranasal salvinorin A improves neurological outcome in rhesus monkey ischemic stroke model using autologous blood clot. J. Cereb. Blood Flow. Metab. 41, 723–730 (2021).
Fang, Z. et al. A MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke. Sci. Trans. Med. 13, eabb6716 (2021).
Gao, Y. et al. Novel acute retinal artery ischemia and reperfusion model in nonhuman primates. Stroke 51, 2568–2572 (2020).
Mergenthaler, P. & Meisel, A. Do stroke models model stroke? Dis. Model. Mech. 5, 718–725 (2012).
Marshall, J. W. et al. Serial MRI, functional recovery, and long-term infarct maturation in a non-human primate model of stroke. Brain Res. Bull. 61, 577–585 (2003).
Boltze, J. et al. New mechanistic insights, novel treatment paradigms, and clinical progress in cerebrovascular diseases. Front. Aging Neurosci. 13, 623751 (2021).
Zhao, B. et al. A more consistent intraluminal rhesus monkey model of ischemic stroke. Neural Regen. Res. 9, 2087–2094 (2014).
de Crespigny, A. J. et al. Acute studies of a new primate model of reversible middle cerebral artery occlusion. J. Stroke Cerebrovasc. Dis. 14, 80–87 (2015).
Fisher, M. Endovascular therapy for basilar-artery occlusion—still waiting for answers. N. Engl. J. Med. 384, 1954–1955 (2021).
Wu, D. et al. Primate version of modified Rankin scale for classifying dysfunction in rhesus monkeys. Stroke 51, 1620–1623 (2020).
Wu, D. et al. Reperfusion plus selective intra-arterial cooling (SI-AC) improve recovery in a nonhuman primate model of stroke. Neurotherapeutics 17, 1931–1939 (2020).
Susumu, T. et al. Effects of intra-arterial urokinase on a non-human primate thromboembolic stroke model. J. Pharmacol. Sci. 100, 278–284 (2006).
Qureshi, A. I. et al. Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a nonhuman primate model. Neuroradiology 47, 845–854 (2005).
Yoshikawa, T. et al. Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates. J. Pharmacol. Sci. 107, 32–40 (2008).
Kuge, Y. et al. Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke. J. Cereb. Blood Flow. Metab. 21, 202–210 (2001).
Jickling, G. C. & Sharp, F. R. Improving the translation of animal ischemic stroke studies to humans. Metab. Brain. Dis. 30, 461–467 (2005).
Yi, K. S. et al. Sustained diffusion reversal with inbore reperfusion in monkey stroke models: confirmed by prospective magnetic resonance imaging. J. Cereb. Blood Flow. Metab. 37, 2002–2012 (2017).
Li, K. et al. Pilot study of endovascular delivery of mesenchymal stromal cells in the aortic wall in a pig model. Cell Transplant. 30, 9636897211010652 (2021).
Camstra, K. M. et al. Canine model for selective and superselective cerebral intra-arterial therapy testing. Neurointervention 15, 107–116 (2020).
Kringe, L. et al. Quality and validity of large animal experiments in stroke: a systematic review. J. Cereb. Blood Flow. Metab. 40, 2152–2164 (2020).
Debatisse, J. et al. A non-human primate model of stroke reproducing endovascular thrombectomy and allowing long-term imaging and neurological read-outs. J. Cereb. Blood Flow. Metab. 41, 745–760 (2021).
Zhang, Z. et al. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106, 740–745 (2002).
Zhang, Z. & Chopp, M. Neural stem cells and ischemic brain. J. Stroke 18, 267–272 (2016).
Gauberti, M. et al. Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI—a pilot study. Cerebrovasc. Dis. 33, 329–339 (2012).
Fisher, M. & Saver, J. L. Future directions of acute ischaemic stroke therapy. Lancet Neurol. 14, 758–767 (2015).
Takamatsu, H. et al. Detection of reperfusion injury using PET in a monkey model of cerebral ischemia. J. Nucl. Med. 41, 1409–1416 (2000).
Sawada, H. et al. SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates. J. Cereb. Blood Flow. Metab. 34, 235–241 (2014).
Grow, D. A., McCarrey, J. R. & Navara, C. S. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson’s disease. Stem Cell. Res. 17, 352–366 (2016).
McEntire, C. R. et al. Impaired arm function and finger dexterity in a nonhuman primate model of stroke: motor and cognitive assessments. Stroke 47, 1109–1116 (2006).
Kito, G. et al. Experimental thromboembolic stroke in cynomolgus monkeys. J. Neurosci. Methods 105, 45–53 (2001).
Cui, L. L., Golubczyk, D., Tolppanen, A. M., Boltze, J. & Jolkkonen, J. Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Ann. Neurol. 86, 5–16 (2019).
Neuhaus, A. A., Couch, Y., Hadley, G. & Buchan, A. M. Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain 140, 2079–2092 (2017).
Tibussek, D. et al. Severe cerebral vasospasm and childhood arterial ischemic stroke after intrathecal cytarabine. Pediatrics 137, e20152143 (2016).
Amlie-Lefond, C. & Wainwright, M. S. Childhood stroke: thinking locally, acting globally? Stroke 52, 162–163 (2021).
Chen, X. et al. An ischemic stroke model of nonhuman primates for remote lesion studies: a behavioral and neuroimaging investigation. Restor. Neurol. Neurosci. 33, 131–142 (2015).
Powers, W. J. Acute ischemic stroke. N. Engl. J. Med. 383, 252–260 (2020).
Cook, D. J. & Tymianski, M. Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics 9, 371–379 (2012).
Dai, P. et al. A pilot study on transient ischemic stroke induced with endothelin-1 in the rhesus monkeys. Sci. Rep. 7, 45097 (2017).
Del Zoppo, G. J. et al. Experimental acute thrombotic stroke in baboons. Stroke 17, 1254–1265 (1986).
Watanabe, O., Bremer, A. M. & West, C. R. Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 1: angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 8, 61–70 (1977).
Cook, D. J., Teves, L. & Tymianski, M. A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates. Sci. Transl. Med. 4, 154ra133 (2012).
D’Arceuil, H. E., Duggan, M., He, J., Pryor, J. & de Crespigny, A. Middle cerebral artery occlusion in Macaca fascicularis: acute and chronic stroke evolution. J. Med. Primatol. 35, 78–86 (2006).
Tong, F. C. et al. An enhanced model of middle cerebral artery occlusion in nonhuman primates using an endovascular trapping technique. Am. J. Neuroradiol. 36, 2354–2359 (2015).
Zhang, X. et al. Temporal evolution of ischemic lesions in nonhuman primates: a diffusion and perfusion MRI study. PLoS ONE 10, e0117290 (2015).
Zhang, L. et al. Focal embolic cerebral ischemia in the rat. Nat. Protoc. 10, 539–547 (2015).
Yonas, H., Wolfson, S. K. Jr., Dujovny, M., Boehnke, M. & Cook, E. Selective lenticulostriate occlusion in the primate. A highly focal cerebral ischemia model. Stroke 12, 567–572 (1981).
Ciccone, A. et al. Endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 368, 904–913 (2013).
Berkhemer, O. A. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372, 11–20 (2015).
Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27–31 (2016).
Higashida, R. T. et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34, 109–137 (2003).
Institute for Laboratory Animal Research. Guide for the care and use of laboratory animals. Washington, DC: National Academies Press (2011).
Won, J. et al. Assessment of hand motor function in a non-human primate model of ischemic stroke. Exp. Neurobiol. 29, 300–313 (2020).
Zhang, Z. et al. A pilot behavioural and neuroimaging investigation on photothrombotic stroke models in rhesus monkeys. J. Neurosci. Methods 362, 109291 (2021).
Sparks, D. S. et al. A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction. Nat. Protoc. 15, 877–924 (2020).
Jia, J. M. et al. Control of cerebral ischemia with magnetic nanoparticles. Nat. Methods 14, 160–166 (2017).
Sneed, S. E. et al. Magnetic resonance imaging and gait analysis indicate similar outcomes between Yucatan and Landrace porcine ischemic stroke models. Front. Neurol. 11, 594954 (2021).
Cattaneo, G. F. et al. Selective intra-carotid blood cooling in acute ischemic stroke: a safety and feasibility study in an ovine stroke model. J. Cereb. Blood Flow. Metab. 41, 3097–3110 (2021).
Shazeeb, M. S. et al. Infarct evolution in a large animal model of middle cerebral artery occlusion. Transl. Stroke Res. 11, 468–480 (2020).
Kurisu, K. et al. Cofilin-actin rod formation in experimental stroke is attenuated by therapeutic hypothermia and overexpression of the inducible 70 kD inducible heat shock protein (Hsp70). Brain Circ. 5, 225–233 (2019).
Shin, H. K. et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 130, 1631–1642 (2007).
Saver, J. L. et al. Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions. Stroke 51, 2872–2884 (2020).
Jia, L., Chopp, M., Zhang, L., Lu, M. & Zhang, Z. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke. Stroke 41, 2071–2076 (2010).
Wu, D. et al. Selective therapeutic cooling: to maximize benefits and minimize side effects related to hypothermia. J. Cereb. Blood Flow. Metab. 42, 213–215 (2022).
McTaggart, R. A. et al. Optimization of endovascular therapy in the neuroangiography suite to achieve fast and complete (expanded treatment in cerebral ischemia 2c-3) reperfusion. Stroke 51, 1961–1968 (2020).
Bouts, M. J. et al. Magnetic resonance imaging-based cerebral tissue classification reveals distinct spatiotemporal patterns of changes after stroke in non-human primates. BMC Neurosci. 16, 91 (2015).
Van Winkle, J. A. et al. Concurrent middle cerebral artery occlusion and intra-arterial drug infusion via ipsilateral common carotid artery catheter in the rat. J. Neurosci. Methods 213, 63–69 (2013).
Tian, H. et al. Influence of occlusion site and baseline ischemic core on outcome in patients with ischemic stroke. Neurology 92, e2626–e2643 (2019).
Chamorro, Á., Lo, E. H., Renú, A., van Leyden, K. & Lyden, P. D. The future of neuroprotection in stroke. J. Neurol. Neurosurg. Psychiatry 92, 129–135 (2021).
van Leyen, K., Wang, X., Selim, M. & Lo, E. H. Opening the time window. J. Cereb. Blood Flow. Metab. 39, 2539–2540 (2019).
Liu, Y. et al. Serial diffusion tensor MRI after transient and permanent cerebral ischemia in nonhuman primates. Stroke 38, 138–145 (2007).
Mărgăritescu, O. et al. Histopathological changes in acute ischemic stroke. Rom. J. Morphol. Embryol. 50, 327–339 (2009).
Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50, e344–e418 (2019).
Li, S. et al. White matter demyelination predates axonal injury after ischemic stroke in cynomolgus monkeys. Exp. Neurol. 340, 113655 (2021).
Spetzler, R. F., Zabramski, J. M., Kaufman, B. & Yeung, H. N. Acute NMR changes during MCA occlusion: a preliminary study in primates. Stroke 14, 185–191 (1983).
Kaiser, E. E. & West, F. D. Large animal ischemic stroke models: replicating human stroke pathophysiology. Neural Regen. Res. 15, 1377–1387 (2020).
Meloni, B. P. et al. Poly-Arginine Peptide-18 (R18) reduces brain injury and improves functional outcomes in a nonhuman primate stroke model. Neurotherapeutics 17, 627–634 (2020).
Harding, J. D. Nonhuman primates and translational research: progress, opportunities, and challenges. ILAR J. 58, 141–150 (2017).
Wu, D., Chandra, A., Chen, J., Ding, Y. & Ji, X. Endovascular ischemic stroke models in nonhuman primates. Neurotherapeutics 15, 146–155 (2018).
Fukuda, S. & del Zoppo, G. J. Models of focal cerebral ischemia in the nonhuman primate. ILAR J. 44, 96–104 (2003).
Sorby-Adams, A. J., Vink, R. & Turner, R. J. Large animal models of stroke and traumatic brain injury as translational tools. Am. J. Physiol. Regul. Integr. Comp. Physiol. 315, R165–R190 (2018).
Bihel, E. et al. Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging, histological, and immunohistochemical investigations. J. Cereb. Blood Flow. Metab. 30, 273–285 (2010).